Phase III Trial Comparing 2 Chemotherapy Schedules (Preoperative vs Pre and Postoperative) in Stage I and II NSCLC
In this multicenter study, patients are randomized to receive either two preoperative
chemotherapy cycles plus two additional preoperative cycles if they respond to chemotherapy,
or two preoperative plus two postoperative cycles in case of response.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Compare 3-Years survival
3 years
Alain Depierre, Pr
Principal Investigator
IFCT
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
IFCT-0002
NCT00198354
May 2001
December 2008
Name | Location |
---|